Literature DB >> 15115753

Hypomorphic expression of Dkk1 in the doubleridge mouse: dose dependence and compensatory interactions with Lrp6.

Bryan T MacDonald1, Maja Adamska, Miriam H Meisler.   

Abstract

doubleridge is a transgene-induced mouse mutation displaying forelimb postaxial polysyndactyly. We have cloned the doubleridge transgene insertion site and demonstrate that doubleridge acts in cis from a distance of 150 kb to reduce the expression of dickkopf 1 (Dkk1), the secreted Wnt antagonist. Expression of Dkk1 from the doubleridge allele ranges from 35% of wild-type level in E7.0 head to <1% of wild type in E13.5 tail. doubleridge homozygotes and doubleridge/null compound heterozygotes are viable. An allelic series combining the wild-type, doubleridge and null alleles of Dkk1 demonstrates the effect of varying Dkk1 concentration on development of limb, head and vertebrae. Decreasing expression of Dkk1 results in hemivertebral fusions in progressively more anterior positions, with severity increasing from tail kinks to spinal curvature. We demonstrated interaction between Dkk1 and the Wnt coreceptors Lrp5 and Lrp6 by analysis of several types of double mutants. The polydactyly of Dkk1(d/d) mice was corrected by reduced expression of Lrp5 or Lrp6. The posterior digit loss and axial truncation characteristic of Lrp6 null mice was partially corrected by reduction of Dkk1. Similarly, the anterior head truncation characteristic of Dkk1 null mice was rescued by reduction of Lrp6. These compensatory interactions between Dkk1 and Lrp6 demonstrate the importance of correctly balancing positive and negative regulation of Wnt signaling during mammalian development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15115753     DOI: 10.1242/dev.01126

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  52 in total

Review 1.  Update on Wnt signaling in bone cell biology and bone disease.

Authors:  David G Monroe; Meghan E McGee-Lawrence; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Gene       Date:  2011-11-03       Impact factor: 3.688

Review 2.  Alternative cell death mechanisms in development and beyond.

Authors:  Junying Yuan; Guido Kroemer
Journal:  Genes Dev       Date:  2010-12-01       Impact factor: 11.361

3.  Transgene insertion in proximity to the c-myb gene disrupts erythroid-megakaryocytic lineage bifurcation.

Authors:  Harumi Y Mukai; Hozumi Motohashi; Osamu Ohneda; Norio Suzuki; Masumi Nagano; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

Review 4.  Dickkopf1: An immunomodulatory ligand and Wnt antagonist in pathological inflammation.

Authors:  Wook-Jin Chae; Alfred L M Bothwell
Journal:  Differentiation       Date:  2019-06-12       Impact factor: 3.880

5.  Developmental expression of Dkk1-3 and Mmp9 and apoptosis in cranial base of mice.

Authors:  Xuguang Nie; Keijo Luukko; Karianne Fjeld; Inger Hals Kvinnsland; Päivi Kettunen
Journal:  J Mol Histol       Date:  2006-03-07       Impact factor: 2.611

Review 6.  Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy.

Authors:  Norann A Zaghloul; Nicholas Katsanis
Journal:  J Clin Invest       Date:  2009-03-02       Impact factor: 14.808

7.  Cell signaling regulation of vertebrate limb growth and patterning.

Authors:  Yingzi Yang; Scott H Kozin
Journal:  J Bone Joint Surg Am       Date:  2009-07       Impact factor: 5.284

8.  DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation.

Authors:  Mikhail V Semënov; Xinjun Zhang; Xi He
Journal:  J Biol Chem       Date:  2008-05-27       Impact factor: 5.157

9.  Fine mapping of an epilepsy modifier gene on mouse Chromosome 19.

Authors:  Sarah K Bergren; Elizabeth D Rutter; Jennifer A Kearney
Journal:  Mamm Genome       Date:  2009-06-10       Impact factor: 2.957

10.  The Fanconi anemia pathway has a dual function in Dickkopf-1 transcriptional repression.

Authors:  Caroline C Huard; Cédric S Tremblay; Audrey Magron; Georges Lévesque; Madeleine Carreau
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.